TABLE 1.

Clinical description of the patients included in this study

Site of tumor	No. of patients	Percent
Larynx	65	76
Pharynx	9	10
Oropharynx	5
Hypopharynx	4
Skin (metastatic)	5	6
Oral cavity	3	3
Unknown origin	2	2
Other	2	2
T-stage
T0–2	25	29
T3	35	40
T4	26	30
N-stage
N0	45	52
N1	13	15
N2–3	28	33